4.7 Article

Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Impaired endothelial vasomotor function after sirolimus-eluting stent implantation

Soichiro Fuke et al.

CIRCULATION JOURNAL (2007)

Article Cardiac & Cardiovascular Systems

Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells

Christian M. Matter et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)

Article Medical Laboratory Technology

Influence of glutathione S-transferase A1 polymorphism on the phartnacokinetics of busulfan

Makiko Kusama et al.

CLINICA CHIMICA ACTA (2006)

Article Hematology

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

C Cutler et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)

Article Immunology

Sirolimus in liver transplantation

JF Trotter

TRANSPLANTATION PROCEEDINGS (2003)

Article Immunology

Rapamycin: Signaling in vascular smooth muscle

AR Marks

TRANSPLANTATION PROCEEDINGS (2003)

Review Urology & Nephrology

Sirolimus (Rapamune) in renal transplantation

RWG Johnson

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2002)

Article Gastroenterology & Hepatology

Orthotopic liver transplantation using low-dose tacrolimus and sirolimus

VC McAlister et al.

LIVER TRANSPLANTATION (2001)